LAO
10 FDA 510(k) clearances · Product code
77 daysmedian time to decision
261 days90th percentile
10clearances measured
FDA profile
- Official device name
- Enzyme Immunoassay, Methotrexate
- Device class
- Unclassified
- Medical specialty
- Unknown
- Adverse events (MAUDE)
- 2007: 5
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| ONLINE TDM Methotrexate (K233454) | Roche Diagnostics Operations | 2024-02-20 |
| ARK Methotrexate II Assay (K232017) | Ark Diagnostics, Inc. | 2023-12-20 |
| ARK Methotrexate Assay (K163359) | Ark Diagnostics, Inc. | 2017-08-18 |
| ARK METHOTREXATE ASSAY, ARK METHOTREXATE CALIBRATOR, ARK METHOTREXATE CONTROL, ARK METHOTREXATE CONTROL (CALIBRATION RAN (K111904) | Ark Diagnostics, Inc. | 2011-10-18 |
| TDX(R)/TDX(R)FLX(R)MEHTOTREXATE II (K932615) | Abbott Laboratories | 1993-07-14 |
| ACA DU PONT METHOTREXATE (MTHO) METHOD (K884744) | E.I. Dupont DE Nemours & Co., Inc. | 1989-01-30 |
| EMIT & METHOFREXATE ASSAY (K833634) | Syva Co. | 1983-12-22 |
| TDX METHOTREXATE (K830398) | Abbott Laboratories | 1983-03-10 |
| EMIT-AND METHOTREXATE ASSAY (K811459) | Syva Co. | 1981-06-09 |
| EMIT METHATREXATE ASSAY (K781381) | Dade Behring, Inc. | 1978-10-10 |
Track LAO automatically
Every clearance here is in the API, with alerts when new ones post.